Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

533 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study).
Kawai T, Matsuyama H, Kobayashi K, Ikeda A, Miyake M, Nishimoto K, Matsushita Y, Nishiyama H, Fujimoto K, Oyama M, Miyake H, Azuma H, Inoue K, Mitsui T, Kawakita M, Oyama C, Mizokami A, Abe T, Kuroiwa H, Kume H. Kawai T, et al. Among authors: nishimoto k. Int J Urol. 2024 May 2. doi: 10.1111/iju.15483. Online ahead of print. Int J Urol. 2024. PMID: 38695571
Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
Kobayashi K, Matsuyama H, Kawai T, Ikeda A, Miyake M, Nishimoto K, Matsushita Y, Komura K, Abe T, Kume H, Nishiyama H, Fujimoto K, Oyama M, Miyake H, Inoue K, Mitsui T, Kawakita M, Ohyama C, Mizokami A, Kuroiwa H. Kobayashi K, et al. Among authors: nishimoto k. Int J Urol. 2022 Jul;29(7):632-638. doi: 10.1111/iju.14854. Epub 2022 Mar 15. Int J Urol. 2022. PMID: 35293022 Free PMC article.
Additional oncological benefit of photodynamic diagnosis with blue light cystoscopy in transurethral resection for primary non-muscle-invasive bladder cancer: A comparative study from experienced institutes.
Miyake M, Nishimura N, Nakahama T, Nishimoto K, Oyama M, Matsushita Y, Miyake H, Fukuhara H, Inoue K, Kobayashi K, Matsumoto H, Matsuyama H, Fujii T, Hirao Y, Fujimoto K. Miyake M, et al. Among authors: nishimoto k. BJUI Compass. 2023 Jan 13;4(3):305-313. doi: 10.1002/bco2.215. eCollection 2023 May. BJUI Compass. 2023. PMID: 37025476 Free PMC article.
Impact on Japanese healthcare economics of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer: A multicenter retrospective cohort study.
Nishimura N, Miyake M, Nakahama T, Miyamoto T, Nishimoto K, Oyama M, Matsushita Y, Miyake H, Fukuhara H, Inoue K, Kobayashi K, Matsumoto H, Matsuyama H, Fujii T, Hirao Y, Fujimoto K. Nishimura N, et al. Among authors: nishimoto k. Int J Urol. 2023 Dec;30(12):1112-1119. doi: 10.1111/iju.15283. Epub 2023 Aug 22. Int J Urol. 2023. PMID: 37605814
Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis.
Matsushita Y, Miyake M, Nishimura N, Nishimoto K, Fukuhara H, Kobayashi K, Oyama M, Inoue K, Matsuyama H, Fujimoto K, Miyake H. Matsushita Y, et al. Among authors: nishimoto k. Int J Clin Oncol. 2024 Feb;29(2):205-212. doi: 10.1007/s10147-023-02447-2. Epub 2023 Dec 19. Int J Clin Oncol. 2024. PMID: 38112832
Identification of risk factors associated with oral 5-aminolevulinic acid-induced hypotension in photodynamic diagnosis for non-muscle invasive bladder cancer: a multicenter retrospective study.
Fukuhara H, Nohara T, Nishimoto K, Hatakeyama Y, Hyodo Y, Okuhara Y, Oyama M, Mizokami A, Inoue K, Matsuyama H; Japan Urological Photodynamic Society. Fukuhara H, et al. Among authors: nishimoto k. BMC Cancer. 2021 Nov 13;21(1):1223. doi: 10.1186/s12885-021-08976-1. BMC Cancer. 2021. PMID: 34774000 Free PMC article.
A case in which bladder cancer invaded the ureteral orifice and was resected via photodynamic diagnosis-assisted transurethral resection involving orally administered 5-aminolevulinic acid.
Watanabe K, Shirotake S, Umezawa Y, Takahashi T, Yamanaka T, L Santo N, Okabe T, Kaneko G, Sano K, Yasuda M, Kanao K, Oyama M, Nishimoto K. Watanabe K, et al. Among authors: nishimoto k. IJU Case Rep. 2019 Sep 13;2(6):313-316. doi: 10.1002/iju5.12109. eCollection 2019 Nov. IJU Case Rep. 2019. PMID: 32743447 Free PMC article.
Efficacy of Androgen Receptor-targeted Drugs After Prostate Cancer Recurrence With Bone Metastases: PROSTAT-BSI Sub-analysis.
Kamijima T, Yaegashi H, Mizokami A, Nakajima K, Matsuyama H, Ichikawa T, Nishimoto K, Takahashi S, Shiina H, Horikoshi H, Hashine K, Sugiyama Y, Miyao T, Kamiyama M, Harada K, Ito A, Enokida H. Kamijima T, et al. Among authors: nishimoto k. Anticancer Res. 2022 Jun;42(6):3099-3108. doi: 10.21873/anticanres.15798. Anticancer Res. 2022. PMID: 35641302
Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivation therapy alone.
Kanao K, Takahashi T, Umezawa Y, Okabe T, Kaneko G, Shirotake S, Nishimoto K, Oyama M. Kanao K, et al. Among authors: nishimoto k. PLoS One. 2022 Oct 20;17(10):e0276081. doi: 10.1371/journal.pone.0276081. eCollection 2022. PLoS One. 2022. PMID: 36264927 Free PMC article.
533 results